Access this stock data via API
Subscribe
Teva Pharmaceutical Industries Ltd. ADR
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 14.1B 15.8B 14.9B 15.9B
Cost of revenue 7.2B 8.2B 8.0B 8.3B
Gross profit 6.9B 7.6B 7.0B 7.6B
Operating expense
Research & development 850.1M 953M 838M 967M
Selling general and admin 3.2B 3.5B 3.4B 3.5B
Other operating expenses
Operating income 2.9B 3.2B 2.7B 3.1B
Non operating interest income
Income
Expense 853.5M 1.0B 930M 891M
Other income expense -3.1B -2.7B -4.9B -1.5B
Pretax income -1.1B -624M -3.2B 658M
Tax provision 575.8M -7M -643M 211M
Net income -1.7B -615M -2.5B 456M
Basic EPS -1.5 -0.5 -2.1 0.4
Diluted EPS -1.5 -0.5 -2.1 0.4
Basic average shares 963.3M 1.2B 1.2B 1.1B
Diluted average shares 963.3M 1.2B 1.2B 1.1B
EBITDA 3.7B 4.3B 3.9B 4.3B
Net income from continuing op. -1.7B -615M -2.5B 456M
Minority interests 320M 56M 53M -39M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 7 minutes

04:52
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).